Sign in to view content

Low-Dose Atropine 0.01% Drops for Symptomatic Vitreous Floaters: A Noninvasive, Safe, and Effective Therapeutic Option

Mohsin H. Ali, MD

Video
Published 2025

Related

Rhegmatogenous Retinal Detachment
Gabriela Lopezcarasa Hernandez, MD
Retina Image Bank: Images of the Week
2012
Assessment of Central Subfield Thickness Fluctuations and Impact on Vision in Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS)
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2021
Real-World Visual Outcomes After YAG Vitreolysis for Vitreous Opacities (VOYAGE)
Netan Choudhry, MD, FRCS(C) FASRS
Updates from the Field
2020

Category: Pharmacology

See more